Home -> Law Blog Directory -> Intellectual Property Law Blogs -> FileWrapper
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: FileWrapperKubin decided: Federal Circuit provides guidance for application of KSR in biotechnology
By McKee, Voorhees & Sease, P.L.C.
Today the Federal Circuit decided the appeal in In re Kubin, a case dealing with how the Supreme Court's KSR decision will apply in the field of biotechnology. The decision is available here. We previously blogged about the BPAI decision here and the Federal Circuit's oral arguments here. Those posts have detailed descriptions of the facts in the case.
The Federal Circuit affirmed the Board's finding that the claims were obvious. As to the applicability of KSR, and specifically the "obvious to try" rational that KSR permits in some cases, the court noted the Supreme Court did not limit KSR to only "predictable arts." Thus, a claim in biotechnology can sometimes be obvious if it would be "obvious to try," noting that language to the contrary in the Deuel case is no longer good law.
Instead, the Federal Circuit quoted its 1988 decision in In re O'Farrell, stating:
It is true that this court and its predecessors have repeatedly emphasized that "obvious to try" is not the standard under § 103. However, the meaning of this maxim is sometimes lost. Any invention that would in fact have been obvious under § 103 would also have been, in a sense, obvious to try. The question is: when is an invention that was obvious to try nevertheless nonobvious?
On this point, the court observed there are at least two such situations. The first is the inverse of the situation contemplated in KSR where a finite number of identified, predictable solutions exist. Such a case exists when "what would have been 'obvious to try' would have been to vary all parameters or try each of numerous possible choices until one possibly arrived at a successful result, where the prior art gave either no indication of which parameters were critical or no direction as to which of many possible choices is likely to be successful." Another situation where an invention would be obvious to try but nonobvious is when "what was 'obvious to try' was to explore a new technology or general approach that seemed to be a promising field of experimentation, where the prior art gave only general guidance as to the particular form of the claimed invention or how to achieve it."
Click below for more detail of the Federal Circuit's analysis of Kubin's claims.
[More]
Full post as published by FileWrapper on April 03, 2009 (boomark / email).
Visa Applications For Foreign Nationals Married to American Citizens
two options for getting your foreign-born spouse a visa
Privacy Protection Act 42 USC 21A
Federal Newsroom Law
Federal Adoption Tax Credit
Financial Incentive for Adoptive Parents
Transportation Equity Act for the 21st Century
TEA-21 - Plus Law 105-178
Specialty Lamp International
Recalls Counterfeit Circuit Breakers
Citizenship and Immigration Canada
allegedly overcharged for immigration application fees.
Taylor Bean Faces Federal WARN Class Action
Taylor Bean Federal Employment Class Action Filed
Arrow Trucking Hit with Federal Lawsuit by Employees
Arrow Trucking Hit with Federal Lawsuit by Employees
California Talent Agency, Be Productions, Faces Federal Class Action
California Talent Agency, Be Productions, Faces Federal Class Action
Parents Bring Federal Lawsuit After Tainted Baby Formula Injures Newborn
Parents Bring Federal Lawsuit After Tainted Baby Formula Injures Newborn

Patent Docs post on Kubin, for which oral argument is Jan. 8
In re Kubin to Be Argued before the Federal Circuit on Thursday
Kubin Panel Questions Motivation behind Reversal in New Written Description Training Materials
Briefs for In re Kubin filed by Amgen and BIO
Federal Circuit Issues Significant Biotech Decisions
In re Kubin: The Obviousness of DNA







